- Report
- May 2025
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- February 2025
- 148 Pages
Global
From €4215EUR$4,850USD£3,668GBP
- Report
- April 2025
- 44 Pages
United States
- Report
- December 2025
- 218 Pages
Global
From €4171EUR$4,799USD£3,630GBP
- Report
- June 2025
- 379 Pages
Global
From €4302EUR$4,950USD£3,744GBP
- Report
- August 2025
- 154 Pages
Global
From €2303EUR$2,650USD£2,004GBP
- Report
- June 2025
- 151 Pages
Global
From €3042EUR$3,500USD£2,647GBP
- Report
- April 2025
- 100 Pages
Global
From €5171EUR$5,950USD£4,501GBP
- Report
- August 2025
- 200 Pages
Global
From €2164EUR$2,490USD£1,883GBP
- Report
- May 2025
- 200 Pages
Global
From €2164EUR$2,490USD£1,883GBP
- Report
- May 2025
- 200 Pages
Global
From €2164EUR$2,490USD£1,883GBP
- Report
- March 2025
- 200 Pages
Global
From €2164EUR$2,490USD£1,883GBP
- Report
- March 2025
- 200 Pages
Global
From €2164EUR$2,490USD£1,883GBP
- Report
- January 2026
- 198 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 184 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 196 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 185 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 182 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 184 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- January 2026
- 184 Pages
Global
From €3423EUR$3,939USD£2,979GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more